Skip to main content
Premium Trial:

Request an Annual Quote

Natera, Mt. Sinai Partner on Genetic Carrier Screening Test

NEW YORK (GenomeWeb) – Natera and the Mount Sinai Genetic Testing Laboratory today announced a partnership to offer Natera's genetic carrier screening test.

The partnership allows Natera to broaden the test called Horizon to include 38 disorders, including an expanded panel designed specifically for Ashkenazi Jewish families, Natera CEO Matthew Rabinowitz said in a statement. The test also provides results for genetic disorders, such as cystic fibrosis, spinal muscular atrophy (SMA), and Tay-Sachs disease. Additionally, the expanded test increases detection rates for SMA over previous testing methods and refines risks for Fragile X syndrome, Natera said.

The Mount Sinai Genetic Testing Laboratory is part of the Icahn School of Medicine at Mount Sinai and offers screening tests for more than 100 disorders. Genetic screening is performed to determine whether an individual is a carrier for certain recessive genetic disorders.

"This is an important addition to Natera's product offering, as we are committed to expanding the breadth of genetic testing services that Natera delivers on a direct basis to our growing network of women's healthcare providers," Rabinowitz said.

Financial and other terms of the partnership were not disclosed.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.